Postmenopausal Osteoporosis Care: Shifting Paradigms and Emerging Therapies

Abstract

Introduction: Osteoporosis, a chronic condition predominantly affecting postmenopausal women, significantly impairs quality of life. While conventional treatments prevail, emerging alternative therapies offer promising solutions for enhanced bone health.

Methodology: This review synthesizes evidence from multiple databases, encompassing traditional therapies (bisphosphonates, calcium, and vitamin D supplementation) and innovative approaches (vibration therapy and bone-building devices like Osteoboost).

Results: Findings confirm the efficacy of traditional treatments in maintaining bone density and reducing fracture risk. Notably, novel therapies demonstrate potential for bone regeneration without medication.

Conclusion: Traditional therapies remain essential, while alternative approaches like vibration therapy offer innovative options for osteoporosis management. Further research is warranted to optimize these therapies and improve patient outcomes.

Abbreviations: BMD = bone mineral density, BPs = bisphosphonates, FDA = Food and Drug Administration, HRT = Hormone Replacement Therapy, PTH = parathyroid hormone, RANKL = receptor activator of nuclear factor-κB ligand, TNF-α = tumor necrosis factor-alpha, WHO = World Health Organization.